会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明申请
    • Method for Decreasing Nicotine and Other Substance Use in Humans
    • US20080175932A1
    • 2008-07-24
    • US12013089
    • 2008-01-11
    • Jie Wu
    • Jie Wu
    • A61K36/18A61K31/4353A61P25/34A61P25/30A61P25/00
    • A61K36/185
    • A method for decreasing nicotine and other substance use in humans is disclosed. Tetrahydroberberine (THB) and its analogs, l-Tetrahydropalmatine (l-THP) and l-Stepholidine (l-SPD), are present in and can be isolated from several plants in the Magnoliidae superorder. According to the disclosed method, THB and its analogs are used to block nicotine-induced DA release, and modulate heterologous or homoeric expression of human nicotinic acetylcholine receptors (nAChR) in humans. Specifically, THB exhibits bi-directory modulation of α4β2-nAChR-mediated currents induced by nicotine. THB also shows predominant inhibition on homologously expressed α7-nAChR function. Thus, according to the disclosed method, THB is used to simultaneous blockade midbrain DA system function, the brain reward center, and neuronal α4β2- and α7-nAChR function, the major nicotine targets in the brain. Therefore, THB and its analogs serve as a novel class of natural compounds to decrease nicotine dependence in humans. Furthermore other substances, such as alcohol, cocaine, and opiates, also operate by triggering the brain reward center, resulting in a cycle of substance or alcohol abuse. THB and its analogs can be used to decrease use of substances such as alcohol, cocaine, and opiates. Finally, because THB and its analogs are DA antagonists, THB and its analogs can also be used as a treatment for Parkinson's Disease, Alzheimer's Disease and Schizophrenia.
    • 23. 发明申请
    • RATE-BASED SENSORS FOR ADVANCED REAL-TIME ANALYSIS AND DIAGNOSTICS
    • 基于速率的传感器,用于高级实时分析和诊断
    • US20070252633A1
    • 2007-11-01
    • US11534412
    • 2006-09-22
    • Jay FrankelMajid KeyhaniRao ArimilliJie Wu
    • Jay FrankelMajid KeyhaniRao ArimilliJie Wu
    • G06G7/18H03K3/011
    • G01D1/10
    • The invention provides a universal rate-based transducer for advancing diagnostic and predictive analyses of low frequency physical phenomena, such as associated with heat and mass transfer, solid and fluid mechanics, pressure and seismic analysis. In many applications, such as in the fire metrology, aerospace, security and defense sectors, rate information is crucial for reaching fast and reliable diagnosis and prediction. In one preferred embodiment, the invention comprises a universal voltage rate sensor interface that accurately recovers the instantaneous heating/cooling rate, dT/dt. Upon appropriate calibration, this sensor interface allows real-time extraction of rates associated with many physical quantities of interest (e.g., temperature, heat flux, concentration, strain, stress, pressure, intensity, etc.).
    • 本发明提供了一种通用的速率传感器,用于进行低频物理现象的诊断和预测分析,例如与热和质量传递,固体和流体力学,压力和地震分析相关联。 在许多应用中,例如在火力计量,航空航天,安防和国防领域,速率信息对于快速可靠的诊断和预测至关重要。 在一个优选实施例中,本发明包括通用电压速率传感器接口,其精确地恢复瞬时加热/冷却速率dT / dt。 通过适当的校准,该传感器接口允许实时提取与许多感兴趣的物理量相关的速率(例如,温度,热通量,浓度,应变,应力,压力,强度等)。
    • 30. 发明授权
    • Indoline scaffold SHP-2 inhibitors and cancer treatment method
    • 吲哚酚支架SHP-2抑制剂和癌症治疗方法
    • US09174969B2
    • 2015-11-03
    • US13055113
    • 2009-07-21
    • Jie WuNicholas J. LawrenceSaid M. Sebti
    • Jie WuNicholas J. LawrenceSaid M. Sebti
    • A61K31/496C07D209/08C07D215/36C07D405/06
    • C07D405/06C07D209/08C07D215/36
    • The subject invention concerns methods and compounds for inhibiting Shp2. In one embodiment, a compound of the invention has a chemical structure as shown in formula I or II: wherein X, Y, and Z are independently N or S; R1 is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; —COOH; —C(R3)3, wherein R3 can independently be any of —H or halogen; or —OR4, wherein R4 can be any of H, alkyl, or heteroalkyl; R2 is alkyl, alkylcarbonyl, heteroalkylcarbonyl, aryl, arylcarbonyl, heterocycloalkylcarbonyl, cycloalkylcarbonyl, or —C(O)NR6R7, any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; carbonyl; —OR4, wherein R4 can be —H, alkyl, or heteroalkyl; —OH; —C(R3)3, wherein R3 can independently be any of —H or halogen; aryl, which can be substituted with one or more of halogen or —OR4; heterocycloalkyl; or —C(O)OR5, wherein R5 can be —H or alkyl; R6 and R7 are independently —H, alkyl, heteroalkyl, aryl, or heteroaryl; and R′ is H or alkyl; or a pharmaceutically acceptable salt or hydrate thereof.
    • 本发明涉及抑制Shp2的方法和化合物。 在一个实施方案中,本发明的化合物具有如式I或II所示的化学结构:其中X,Y和Z独立地为N或S; R 1是环烷基,杂环烷基,芳基或杂芳基,其中任何一个可以任选被一个或多个卤素取代; 烷基; 杂烷基; -COOH; -C(R 3)3,其中R 3可以独立地为-H或卤素; 或-OR 4,其中R 4可以是H,烷基或杂烷基中的任何一个; R 2是烷基,烷基羰基,杂烷基羰基,芳基,芳基羰基,杂环烷基羰基,环烷基羰基或-C(O)NR 6 R 7,其中任何一个可以任选被一个或多个卤素取代; 烷基; 杂烷基; 羰; -OR4,其中R4可以是-H,烷基或杂烷基; -哦; -C(R 3)3,其中R 3可以独立地为-H或卤素; 芳基,其可被一个或多个卤素或-OR 4取代; 杂环烷基; 或-C(O)OR 5,其中R 5可以是-H或烷基; R6和R7独立地是-H,烷基,杂烷基,芳基或杂芳基; 和R'是H或烷基; 或其药学上可接受的盐或水合物。